Cover Image
Market Research Report

Peptic Ulcer Drugs Market, By Product Type, By Disease Indication, By Distribution Channel, By Region - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

Published by Coherent Market Insights Product code 920709
Published Content info 204 Pages
Delivery time: 2-3 business days
Price
Back to Top
Peptic Ulcer Drugs Market, By Product Type, By Disease Indication, By Distribution Channel, By Region - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027
Published: January 2, 2020 Content info: 204 Pages
Description

Title:
Peptic Ulcer Drugs Market, By Product Type (Proton Pump Inhibitors, Potassium-Competitive Acid Blocker (P-CAB), Antacids, H2- Antagonists, Antibiotics, Ulcer Protective), By Disease Indication (Gastritis, Gastric Ulcer, Duodenal Ulcer, Gastroesophageal Reflux Disease (GERD)), By Distribution Channel (Hospital Pharmacies, Private Clinics, Drug Stores, Retail Pharmacies, E-Commerce), By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027.

Peptic ulcers are also classed as stomach ulcers or gastric ulcers can cause abdominal pain and discomfort in the abdomen. There are two types of peptic ulcer found gastric ulcer and duodenal ulcer. Gastric ulcers are commonly found in the inner lining of the stomach whereas the duodenal ulcers are formed in small intestines. Peptic ulcers are caused due to reduction of mucus layer that protects the stomach from digestive juices. Major symptoms of peptic ulcers constitute of burping, nausea, vomiting, loss in appetite, and etc. The treatment of peptic ulcers depend on the type of ulcer and the treatment regime mostly comprises of proton pump inhibitors, and antibiotics.

Key features of the study::

  • This report provides in-depth analysis of the Peptic Ulcer Drugs market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2019-2027), considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global Peptic Ulcer Drugs market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Daewoong Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Pfizer Inc., Abbott Laboratories, AstraZeneca plc., RedHill Biopharma, Cadila Healthcare Ltd., Novitium Pharma LLC, Boehringer Ingelheim GmbH, Eisai Co. Ltd., Yuhan Corporation, and GlaxoSmithKline plc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global Peptic Ulcer Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Peptic Ulcer Drugs market

Detailed Segmentation::

  • Peripheral Intravenous Catheter Market, By Product Type:
    • Proton Pump Inhibitors
    • Potassium-Competitive Acid Blocker (P-CAB)
    • Antacids
    • H2- Antagonists
    • Antibiotics
    • Ulcer Protective
  • Peripheral Intravenous Catheter Market, By Disease Indication:
    • Gastritis
    • Gastric Ulcer
    • Duodenal Ulcer
    • Gastroesophageal Reflux Disease (GERD)
  • Peripheral Intravenous Catheter Market, By Distribution Channel:
    • Hospital Pharmacies
    • Private Clinics
    • Drug Stores
    • Retail Pharmacies
    • E-Commerce
  • Peripheral Intravenous Catheter Market, By Region:
    • North America
      • By Product Type:
      • Proton Pump Inhibitors
      • Potassium-Competitive Acid Blocker (P-CAB)
      • Antacids
      • H2- Antagonists
      • Antibiotics
      • Ulcer Protective
      • By Disease Indication
      • Gastritis
      • Gastric Ulcer
      • Duodenal Ulcer
      • Gastroesophageal Reflux Disease (GERD)
      • By Distribution Channel
      • Hospital Pharmacies
      • Private Clinics
      • Drug Stores
      • Retail Pharmacies
      • E-Commerce
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Product Type:
      • Proton Pump Inhibitors
      • Potassium-Competitive Acid Blocker (P-CAB)
      • Antacids
      • H2- Antagonists
      • Antibiotics
      • Ulcer Protective
      • By Disease Indication
      • Gastritis
      • Gastric Ulcer
      • Duodenal Ulcer
      • Gastroesophageal Reflux Disease (GERD)
      • By Distribution Channel
      • Hospital Pharmacies
      • Private Clinics
      • Drug Stores
      • Retail Pharmacies
      • E-Commerce
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Product Type:
      • Proton Pump Inhibitors
      • Potassium-Competitive Acid Blocker (P-CAB)
      • Antacids
      • H2- Antagonists
      • Antibiotics
      • Ulcer Protective
      • By Disease Indication
      • Gastritis
      • Gastric Ulcer
      • Duodenal Ulcer
      • Gastroesophageal Reflux Disease (GERD)
      • By Distribution Channel
      • Hospital Pharmacies
      • Private Clinics
      • Drug Stores
      • Retail Pharmacies
      • E-Commerce
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Product Type:
      • Proton Pump Inhibitors
      • Potassium-Competitive Acid Blocker (P-CAB)
      • Antacids
      • H2- Antagonists
      • Antibiotics
      • Ulcer Protective
      • By Disease Indication
      • Gastritis
      • Gastric Ulcer
      • Duodenal Ulcer
      • Gastroesophageal Reflux Disease (GERD)
      • By Distribution Channel
      • Hospital Pharmacies
      • Private Clinics
      • Drug Stores
      • Retail Pharmacies
      • E-Commerce
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Product Type:
      • Proton Pump Inhibitors
      • Potassium-Competitive Acid Blocker (P-CAB)
      • Antacids
      • H2- Antagonists
      • Antibiotics
      • Ulcer Protective
      • By Disease Indication
      • Gastritis
      • Gastric Ulcer
      • Duodenal Ulcer
      • Gastroesophageal Reflux Disease (GERD)
      • By Distribution Channel
      • Hospital Pharmacies
      • Private Clinics
      • Drug Stores
      • Retail Pharmacies
      • E-Commerce
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Product Type:
      • Proton Pump Inhibitors
      • Potassium-Competitive Acid Blocker (P-CAB)
      • Antacids
      • H2- Antagonists
      • Antibiotics
      • Ulcer Protective
      • By Disease Indication
      • Gastritis
      • Gastric Ulcer
      • Duodenal Ulcer
      • Gastroesophageal Reflux Disease (GERD)
      • By Distribution Channel
      • Hospital Pharmacies
      • Private Clinics
      • Drug Stores
      • Retail Pharmacies
      • E-Commerce
      • By Country:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Daewoong Pharmaceutical Co., Ltd. *
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Takeda Pharmaceutical Co., Ltd.
    • Pfizer Inc.
    • AstraZeneca plc.
    • RedHill Biopharma
    • Cadila Healthcare Ltd.
    • Novitium Pharma LLC.
    • Boehringer Ingelheim GmbH
    • Eisai Co. Ltd.
    • Yuhan Corporation
    • GlaxoSmithKline plc.
  • "*" marked represents similar segmentation in other categories in the respective section.
Table of Contents

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippets, By Disease Indication
    • Market Snippets, By Distribution Channel
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Highlights
  • Product launch
  • PEST Analysis
  • Regulatory Scenario
  • Mergers and Acquisitions

4. Global Peptic Ulcer Drugs Market, By Product Type, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Proton Pump Inhibitors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Potassium-Competitive Acid Blocker (P-CAB)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Antacids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • H2- Antagonists
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Antibiotics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Ulcer Protective
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

5. Global Peptic Ulcer Drugs Market, By Disease Indication, 2019 - 2027, (US$ Mn)

  • Gastitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Gastric Ulcer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Duodenal Ulcer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Gastroesophageal Reflux Disease (GERD)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

6. Global Peptic Ulcer Drugs Market, By Distribution Channel, 2019 - 2027, (US$ Mn)

  • Hospitals Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Private Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Drug Stores
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • E-Commerce
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

7. Global Peptic Ulcer Drugs Market, By Region, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
  • North America
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of APAC
  • Middle East
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

8. Competitive Landscape

  • Company Profiles
    • Daewoong Pharmaceutical Co., Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Takeda Pharmaceutical Co., Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Pfizer Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • AstraZeneca plc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • RedHill Biopharma
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Cadila Healthcare Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Novitium Pharma LLC.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Boehringer Ingelheim GmbH
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Eisai Co. Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Yuhan Corporation
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • GlaxoSmithKline plc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Back to Top